Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of oncolytic herpes simplex virus, alone or in combination with immune check-point inhibitor, in the treatment of cancer

Use of oncolytic herpes simplex virus, alone or in combination with immune check-point inhibitor, in the treatment of cancer

US Patent 10813958 · Granted Oct 27, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oncolytic herpes simplex virus infected cells2023
Oncolytic herpes simplex virus infected cells2020
Mutant HSV, materials and methods for generation of mutant HSV2015
Viruses2015
Herpes simplex viruses and methods of viral replication2015
Herpes simplex virus complex2014
Herpes simplex viruses and methods of viral replication2012
Herpes simplex virus complex2011
Prioritizing electronic messages based on the sender's address2005
System and method for prioritizing communications messages2002